ORCID
- Jeremy Hobart: 0000-0002-2114-7920
DOI Link
DOI
10.1093/ecco-jcc/jjaa104
Publication Date
2020-05-04
Publication Title
Journal of Crohn's and Colitis
ISSN
1873-9946
Embargo Period
2021-05-04
Recommended Citation
Ahmad, T., Lin, S., Green, H., Hendy, P., Heerasing, N., Chanchlani, N., Hamilton, B., Walker, G., Heap, G., Hobart, J., Martin, R., Coles, A., Irving, P., Chung-Faye, G., Cummings, J., Lytvyak, E., Andersen, V., Wood, A., Tyrrell, J., Beaumont, R., Weedon, M., Kennedy, N., Spiers, A., Harrower, T., & Goodhand, J. (2020) 'Clinical features and genetic risk of demyelination following anti-TNF treatment', Journal of Crohn's and Colitis, . Available at: 10.1093/ecco-jcc/jjaa104
